Biotech developing gene therapies for the treatment of orphan diseases.
Industry: Health Care
First Day Return: -14.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 01/02/2014 |
Offer Price | $17.00 |
Price Range $13.00 - $15.00 | |
Offer Shares (mm) | 5.4 |
Deal Size ($mm) | $92 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 02/04/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $92 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Amsterdam, Netherlands |
Founded | 1998 |
Employees at IPO | 87 |
Website www.uniqure.com |